Dr. Eleonora D’Ambrosio was born and raised in Italy where she also attended medical school at Sapienza University, in Rome. Following her graduation from medical school, Dr. D’Ambrosio moved to the USA where she began her research career in the laboratory of Dr. Sena-Esteves at the University of Massachusetts. There, her interest in gene therapy for rare neuromuscular diseases took root and brought her to complete a neurology residency at the University of Massachusetts, followed by a Neuromuscular fellowship at Massachusetts General Brigham. Her dream of becoming a clinician scientist brought her to pursue a second fellowship in gene therapy at Nationwide Children’s Hospital, in Columbus, where she works both in the clinical and the laboratory setting. In this dynamic environment, Dr. D’Ambrosio is working to develop and translate novel therapeutic strategies for neuromuscular diseases, including Duchenne Muscular Dystrophy, Limb Girdle Muscular Dystrophy, Myotonic Dystrophy. Collaborating with her mentor and director of the CRISPR core, Dr. Naeimi-Kararoudi, Dr. D’Ambrosio is focusing on developing a CRISPR-gene editing strategy for Valosin Containing Protein (VCP) disease.